TY - JOUR
T1 - Developing standardized titles to classify the adverse events in 7,418 cranial and spinal neurosurgical procedures
AU - Al Saiegh, Fadi
AU - Mazza, Jacob
AU - Hafazalla, Karim
AU - Baldassari, Michael P.
AU - Theofanis, Thana
AU - Ye, Donald
AU - Hoelscher, Christian
AU - Harrop, James S.
AU - Evans, James J.
AU - Jabbour, Pascal
AU - Rosenwasser, Robert H.
AU - Sharan, Ashwini D.
N1 - Publisher Copyright:
© 2020 Elsevier B.V.
PY - 2020/11
Y1 - 2020/11
N2 - Background: Neurosurgical procedures are life- and function-saving but carry a risk of adverse events (AE) which can cause permanent neurologic deficits. Unfortunately, there is lack of clearly defined AEs associated with given procedures, and their reporting is non-uniform and often arbitrary. However, with an increasing number of neurosurgical procedures performed, there is a need for standardization of AEs for systematic tracking. Such a system would establish a baseline for future quality improvement strategies. Objective: To review our institutional AEs and devise standardized titles specific to the spine, tumor, functional, and vascular neurosurgery divisions. Methods: A review of prospective monthly-reported morbidity and mortality (M&M) conference data within the Department of Neurological Surgery was conducted from January 2017 to December 2019. An AE was defined as any mortality, an “unintended and undesirable diagnostic or therapeutic event”, “an event that prolongs the patient's hospital stay”, or an outcome with permanent or transient neurologic deficit. Results: A total of 1096 AEs from 7418 total procedures (14.8 %) were identified. Of those, 418 (5.6 %) were in cerebrovascular, 249 (3.4 %) were in neuro-oncology and 429 (5.8 %) were in the spine & functional divisions. The most common AEs across all divisions were infection (17 %), hemorrhage (11 %) and cerebrospinal fluid (CSF) leak (7.8 %). Other AEs were indirectly related to the neurosurgical procedure, such as deep vein thrombosis or pulmonary embolism (2.7 %), or pneumothorax (0.3 %). Conclusion: This work illustrates standardized AEs can be implemented universally across the spectrum of neurological surgery. Standardization can help identify recurring AE patterns through better tracking.
AB - Background: Neurosurgical procedures are life- and function-saving but carry a risk of adverse events (AE) which can cause permanent neurologic deficits. Unfortunately, there is lack of clearly defined AEs associated with given procedures, and their reporting is non-uniform and often arbitrary. However, with an increasing number of neurosurgical procedures performed, there is a need for standardization of AEs for systematic tracking. Such a system would establish a baseline for future quality improvement strategies. Objective: To review our institutional AEs and devise standardized titles specific to the spine, tumor, functional, and vascular neurosurgery divisions. Methods: A review of prospective monthly-reported morbidity and mortality (M&M) conference data within the Department of Neurological Surgery was conducted from January 2017 to December 2019. An AE was defined as any mortality, an “unintended and undesirable diagnostic or therapeutic event”, “an event that prolongs the patient's hospital stay”, or an outcome with permanent or transient neurologic deficit. Results: A total of 1096 AEs from 7418 total procedures (14.8 %) were identified. Of those, 418 (5.6 %) were in cerebrovascular, 249 (3.4 %) were in neuro-oncology and 429 (5.8 %) were in the spine & functional divisions. The most common AEs across all divisions were infection (17 %), hemorrhage (11 %) and cerebrospinal fluid (CSF) leak (7.8 %). Other AEs were indirectly related to the neurosurgical procedure, such as deep vein thrombosis or pulmonary embolism (2.7 %), or pneumothorax (0.3 %). Conclusion: This work illustrates standardized AEs can be implemented universally across the spectrum of neurological surgery. Standardization can help identify recurring AE patterns through better tracking.
KW - Adverse events
KW - Complications
KW - Morbidity and mortality
KW - Standardize
UR - http://www.scopus.com/inward/record.url?scp=85089436057&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089436057&partnerID=8YFLogxK
U2 - 10.1016/j.clineuro.2020.106121
DO - 10.1016/j.clineuro.2020.106121
M3 - Article
C2 - 32818755
AN - SCOPUS:85089436057
SN - 0303-8467
VL - 198
JO - Clinical Neurology and Neurosurgery
JF - Clinical Neurology and Neurosurgery
M1 - 106121
ER -